Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

EFSA: conflicts of interest on board

The European Food Safety Authority (EFSA) is responsible for assessing and communicating food safety in the European Union, for everything from genetically modified organisms (GMOs) to pesticides. However EFSA has recently been criticised because its scientific assessments of new GM crops and pesticides rely almost exclusively on corporate research data. Some EFSA experts have also been accused of being too close to the food and drink industry . Several cases of ‘revolving doors’ (where EFSA employees move straight to industry, or from industry to EFSA) and conflicts of interest have been highlighted. Now, Corporate Europe Observatory (CEO) has discovered that three EFSA board members are advisors for Big Food companies, working through industry-funded think tanks which aim to manipulate political and scientific debate concerning food risks. A fourth member of the board is director of a fund which has shares in a company selling GM feed. Those conflicts of interest risk influencing the judgement of these board members when involved in EFSA’s work, in particular when they establish work programmes and appoint members of the agency’s scientific committee and panels.

 

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

This May is dense on the EU chemicals regulation front. Crunch time for two major files: the European Commission needs to publish the identification criteria for endocrine disrupting chemicals, and together with EU States must decide how, or not, renew the market approval of glyphosate, an herbicide produced and defended by Monsanto. Last week, the Professor Alan Boobis happened to be involved in both.

Demonstrating the problematic symbiosis between corporate interests and EU institutions, the same lobbying consultancies often get hired by both.

Biodiversity collapse, the future of agriculture, politics versus science, EU States and the European Commission shifting blame on each other, industry's capture of the regulatory process through data secrecy, a Commissioner caught between Juncker, EU States, lobby groups, and his own services... The glyphosate saga, coming to an end this week with the European Commission's decision to extend its licence, has been an entry point into many broader problems. Overview.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

The current struggle in France over labour law reforms is not just between the Government and trade unions – a European battle is waged. The attacks on social rights stem in no small part from the web of EU-rules dubbed 'economic governance', invented to impose austerity policies on member states.

 
 
 
 
 
-- placeholder --
 
 
 

The corporate lobby tour